Besides, targeting AMPK/PGC-1α-mediated mitochondrial biogenesis may alleviate motor deficits and degeneration of dopaminergic neurons in PD model mice (Cheng et al., 2021). This evidence concerns the gene PPARGC1A and Parkinson disease.